Education
About Us
Working with TipRanks
Follow Us
Artivion (DE:CYL)
FRANKFURT:CYL
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.11Last Year’s EPS
0.17Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 24, 2025
|% Change Since: -17.01%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a strong financial performance for 2024, with impressive revenue and EBITDA growth and successful product approvals. However, the company faced challenges due to a cybersecurity incident that impacted Q4 results and led to delays in product processing and PMA approval for AMDS. Despite these setbacks, the positive developments in product approvals and international growth suggest optimism for 2025.Company Guidance
During the Artivion Fourth Quarter and Year End 2024 Financial Conference Call, the company provided guidance for 2025, projecting constant currency revenue growth between 10% and 14%, translating to a reported revenue range of $420 million to $435 million. They anticipate a 2 percentage point negative impact from foreign currency. Artivion expects adjusted EBITDA to grow by 18% to 28%, reaching between $84 million and $91 million, with a 200 basis point expansion in adjusted EBITDA margin at the midpoint. The company plans for a 100 basis point improvement in gross margins, driven by the launch of the AMDS Humanitarian Device Exemption (HDE) in the U.S. They also anticipate R&D expenses to rise to approximately 8% of sales for 2025. Artivion's guidance reflects confidence in overcoming the short-term disruptions from a recent cybersecurity incident and in achieving sustained double-digit revenue growth while growing EBITDA at least twice the rate of constant currency revenue growth.Strong Constant Currency Revenue Growth
Artivion achieved a total constant currency revenue growth of 10% excluding PerClot. The company also expanded EBITDA margins by 310 basis points, resulting in adjusted EBITDA growth of 32% year-over-year.
On-X Revenue Growth
On-X revenue increased 10% year-over-year on a constant-currency basis, driven by market share gains globally and positive feedback from the field.
AMDS HDE Approval and Impact
The AMDS received a Humanitarian Device Exemption (HDE), allowing for commercial distribution in the U.S. prior to PMA approval. Significant clinical benefits include a 72% reduction in mortality and 54% reduction in major adverse events compared to standard care.
Stent Graft Revenue Growth
Stent graft revenues grew 8% on a constant currency basis in Q4, with significant opportunities in Europe and plans to expand to the U.S. and Japanese markets.
BioGlue Approval in China
BioGlue received regulatory approval in China, with commercialization expected in the second half of 2025. The product is anticipated to benefit approximately 12,000 patients annually in China.
Strong International Revenue Performance
Latin America and Asia-Pacific delivered constant-currency revenue growth of 26% and 11% for the full year, respectively.
---
DE:CYL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:CYL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 24, 2025 | €26.75 | €25.30 | -5.42% |
| Nov 07, 2024 | €27.20 | €26.75 | -1.65% |
| Aug 08, 2024 | €22.90 | €23.05 | +0.66% |
| May 06, 2024 | €19.38 | €19.84 | +2.37% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Artivion (DE:CYL) report earnings?
Artivion (DE:CYL) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is Artivion (DE:CYL) earnings time?
Artivion (DE:CYL) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Artivion stock?
The P/E ratio of Artivion is N/A.
What is DE:CYL EPS forecast?
DE:CYL EPS forecast for the fiscal quarter 2025 (Q1) is -0.11.
---